Keywords: Bioresorbable vascular scaffold; BRS; Bioabsorbable vascular scaffold; BVS; Stents coronaires biorésorbables; BRS; Stents coronaires bioabsorbables; BVS; BVS; bioresorbable vascular scaffold; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; MACE
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Peripheral arterial disease (PAD); Atherosclerotic cardiovascular disease (ASCVD); Multiple vascular beds; Antiplatelet agents; Statin; Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; Cardiovascular; FOURIER; CHD; Hypertension; MI, s
Keywords: OPN; osteopontin; ACS; acute coronary syndromes; MACE; major adverse cardiovascular events; IL-6; interleukin-6; CEA; carotid endarterectomy; ECST; European Carotid Surgery Trial; ACST; Asymptomatic Carotid Surgery trial; IS; ischemic stroke; York NYHA; H
Keywords: Acute myocardial infarction; Acute Coronary Syndromes; Diagnosis; Sensitivity and specificity; Troponins; Troponins, high sensitivity; Emergency medicine; ED; Emergency Department; AMI; Acute myocardial infarction; cTn; Cardiac troponin; hs-cTn; High sens
Keywords: ACS; Acute Coronary Syndrome; AF; atrial fibrillation; BMS; bare metal stent; CV; cardiovascular; DAPT; dual antiplatelet therapy; DES; drug eluting stent; OAC; oral anticoagulant; MACE; major adverse cardiovascular event; MI; myocardial infarction; NOAC;
Keywords: Uric acid; Hyperuricemia; Acute coronary syndrome; Percutaneous coronary intervention; Long-term adverse outcomes; ACE-I; angiotensin-converting-enzyme inhibitor; ACS; acute coronary syndrome; ARB; angiotensin-receptor blocker; ASS; acetylsalicylic acid;
Keywords: ROC; receiver operating characteristic; MACE; mean absolute calibration error; Predictive modelling; Data mining; Evaluation; Calibration; Deviance; Discrimination;
Keywords: cardiovascular; composites; hemodialysis; outcomes; CVD; cardiovascular disease; MACE; major adverse cardiac event(s);
Keywords: AF; atrial fibrillation; AHA; American Heart Association; AHRQ; Agency of Healthcare Research and Quality; ALA; alpha-linolenic acid; ASA; aspirin; BP; blood pressure; CHD; coronary heart disease; CKD; chronic kidney disease; CV; cardiovascular; CVD; card
Keywords: Acute coronary syndrome; Myocardial damage; Microcirculation; Syndrome coronarien aigu; Dommage myocardique; Microcirculation coronaire; ACS; acute coronary syndrome; CFR; coronary flow reserve; CMR; cardiac magnetic resonance; FFR; fractional flow reserv
Keywords: cardio-oncology; checkpoint inhibitor; ipilimumab; myocarditis; nivolumab; pembrolizumab; anti-CTLA4; anti-cytotoxic T-lymphocyte-associated protein 4; anti-PD1; anti-programmed cell death protein 1; anti-PDL1; anti-programmed death-ligand 1; AUC; area un
Keywords: chronic total occlusion; percutaneous coronary intervention; stable coronary artery disease; CABG; coronary artery bypass grafting; CTA; computed tomography angiography; CTO; chronic total occlusion; IVUS; intravascular ultrasound; MACE; major adverse ca
Keywords: bifurcation lesion; left main coronary artery; percutaneous coronary intervention; ACS; acute coronary syndrome(s); CABG; coronary artery bypass; C-DES; current-generation drug-eluting stent(s); CI; confidence interval; CKD; chronic kidney disease; DES; d
Keywords: HIV; human immunodeficiency virus; SA; South Africa; NOx; oxides of nitrogen; BW; birthweight; Nrf2; nuclear factor (erythroid-derived 2)-like 2; Keap1; kelch-like ECH-associated protein 1; mi-RNA; microRNA; NO; nitrites/nitrates; MDA; malondialdehyde; ER
Keywords: new-generation drug-eluting stents; patient-level pooled analysis of women; percutaneous coronary intervention; stent length per lesion; stent length per patient; CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); HR; ha
Keywords: ACS; acute coronary syndrome; Hgb; hemoglobin; IPW; inverse propensity weighting; MACE; major adverse cardiac events; MI; myocardial infarction; NSTEMI; non-ST-elevation MI; OR; odds ratio; PCI; percutaneous coronary intervention; RCT; randomized contro
Keywords: CVD; cardiovascular diseases; CCT; cardiac cell therapy; AMI; acute myocardial infarction; RA; refractory angina; CHF; chronic heart failure; BM-MNC; bone marrow mononuclear cells; SKM; skeletal myoblasts; EPC; endothelial progenitor cells; MSC; mesenchym
Keywords: adipose tissue; antiobesity drugs; bariatric surgery; obesity; overweight; weight loss; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; CVOT; cardiovascular outcomes trial; FDA; Food and Drug Administration; HF; heart failure;
Keywords: Diabetes type 2; SGLT2 inhibitors; Cardiovascular disease; Kidney disease; Safety; Amputation; Fracture; Systematic review; Randomised controlled trials; AKI; Acute kidney impairment; CVD; Cardiovascular disease; MACE; Major macrovascular event; SGLT2; So
Keywords: ACR; Albumin-to-creatinine ratio; Alb+CKD; Albuminuric chronic kidney disease; AlbâCKD; Non-albuminuric chronic kidney disease; ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; CKD; Chronic kidney disease; CVD; Cardiovascular disease; ERF
Keywords: T2DM; type 2 diabetes; IR; insulin resistance; HbA1c; glycated hemoglobin A1c; GLUT-4; glucose transporter4; GLP-1; glucagon-like peptide-1; DPP4; dipeptidyl peptidase; eGFR; estimated glomerular filtration rate; HF; heart failure; UKPDS; United Kingdom P
Keywords: ACS; acute coronary syndrome; CABG; coronary artery bypass grafting; CAD; coronary artery disease; IABP; intra-aortic balloon pump; LM; left main; MACE; major adverse cardiac event; MI; myocardial infarction; NSTEMI; non-ST-elevation myocardial infarction
Keywords: 4 years; interleukin 17; ixekizumab; long-term; open-label; psoriasis; BCC; basal cell carcinoma; DLQI; Dermatology Life Quality Index; HADS; Hospital Anxiety and Depression Scale; IBD; inflammatory bowel disease; IL; interleukin; LOCF; last observation c
Keywords: ACS; acute coronary syndrome; BARC; Bleeding Academic Research Consortium; BMS; Bare metal stent; BP-BES; biodegradable polymer coated biolimus-A9 eluting stents; BP-SES; biodegradable polymer coated sirolimus eluting stents; BVS; bioresorbable vascular s
Keywords: adverse cardiovascular event; atrial fibrillation; cardiac surgery; mortality; CABG; coronary artery bypass grafting; CCU; coronary care unit; CI; confidence interval; COPD; chronic obstructive pulmonary disease; ECG; electrocardiogram; HR; hazard ratio;
Keywords: ACS; acute coronary syndrome; ADP; advanced diagnostic pathway; CCTA; coronary computed tomography angiography; cTn; cardiac troponin; ECG; electrocardiogram; ED; emergency department; ESC; European Society of Cardiology; Hs-cTn; high-sensitivity cardiac
Keywords: MACE; Malone antegrade continent enema; SSI; surgical site infection; GIA; gastrointestinal anastomosis; Ventriculoperitoneal shunt; Infection; Myelodysplasia; Urologic surgical procedures;
Keywords: BRS; bioresorbable scaffold; DAPT; dual antiplatelet therapy; MACE; major adverse cardiac event; ST; stent or scaffold thrombosis; TAT; triple antithrombotic therapy; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel fai
Keywords: CABG; coronary artery bypass grafting; CI; confidence interval; JACVSD; Japan Adult Cardiovascular Surgery Database; MACE; major adverse cardiac events; OR; odds ratio; PCI; percutaneous coronary intervention;
Keywords: Primary percutaneous coronary intervention; MACE; SYNTAX score clinical SYNTAX score; ACEF; GRS; EuroSCORE; EuroSCORE II;
Keywords: cTn; cardiac troponin; MACE; major adverse cardiac events; hs-cTn; high sensitivity cardiac troponin; RCT; randomized controlled trial; NPV; negative predictive; CI; confidence interval; ADP; accelerated diagnostic pathway; ED; emergency department; ACS;
Keywords: CVD; cardio vascular disease; NCD; non-nommunicable disease; MONICA; multinational MONItoring of trends and determinants in CArdiovascular disease; CHD; coronary heart disease; ACS; acute coronary syndrome; TG; triglyceride; LDL-C; low density lipoprotein
Keywords: CoronariografÃa por tomografÃa computarizada; Tejido adiposo visceral; Obesidad abdominal; Enfermedad cardiovascular; Enfermedad arterial coronaria; Cardiac computed tomography; Visceral adipose tissue; Abdominal obesity; Cardiovascular disease; Coronar
Keywords: complex PCI; robotic PCI; CK; creatine kinase; MA; manual assistance; MACE; major adverse cardiovascular event(s); MC; manual conversion; MI; myocardial infarction; M-PCI; manual percutaneous coronary intervention; PCI; percutaneous coronary intervention;
Keywords: C-IMT; carotid intima-media thickness test; CV; cardiovascular; DPP4; dipeptidyl peptidase-4; DPP4i; DPP4 inhibitors; GLP1; glucagon-like peptide 1; HbA1c; glycated haemoglobin; HF; heart failure; HR; hazard ratio; MACE; major adverse cardiac event; MI;
Keywords: chronic total occlusion; collateral circulation; coronary physiology; prognosis; ATO; acute coronary syndrome with total or nearly total occlusion; CPI; collateral pressure index; CTO; chronic total coronary occlusion; DES; drug-eluting stent(s); FFRcor;
Keywords: BMI; body mass index; CABG; coronary artery bypass graft; CHF; congestive heart failure; CKD; chronic kidney disease; CRF; cardiorespiratory fitness; ETT; exercise tolerance test; HR; hazard ratio; MACE; major adverse cardiovascular event; MET; metabolic
Keywords: Dipyridamole stress echocardiography; Coronary flow velocity reserve; Transthoracic Doppler; Diabetes; Screening; Asymptomatic; BARDOT; Asymptomatic High-Risk Diabetics' Outcome Trial; CAD; Coronary artery disease; CFVR; Coronary flow velocity reserve; DI
Keywords: blood glucose; cardiovascular disease; heart failure; hypoglycemic agents; outcomes; CI; confidence interval; CV; cardiovascular; CVOT; cardiovascular outcomes trial; GLP; glucagon-like peptide; HbA1c; glycosylated hemoglobin; HR; hazard ratio; MACE; majo
Keywords: atherosclerotic plaque; coronary artery disease; major adverse cardiac events; nonculprit plaque; ACS; acute coronary syndrome; AMI; acute myocardial infarction; LRP; lipid-rich plaque; MACE; major adverse cardiac event(s); NC-MACE; nonculprit lesion-rela
Keywords: emergency department; noninvasive imaging; randomized clinical trial; ACP; acute chest pain; ACS; acute coronary syndrome; CAD; coronary artery disease; CTA; computed tomographic angiography; CMR; cardiac magnetic resonance imaging; ECG; electrocardiogra
Keywords: cardiac magnetic resonance imaging; heart failure; implantable cardioverter-defibrillator; major adverse cardiac events; pacing; aHR; adjusted hazard ratio; CI; confidence interval; CMR; cardiac magnetic resonance; CRT; cardiac resynchronization therapy;
Keywords: atherosclerosis; coronary disease; vulnerable plaque; ACS; acute coronary syndrome(s); FA; fibroatheroma; FEA; finite element analysis; GS; gray-scale; IVUS; intravascular ultrasound; LAD; left anterior descending; MACE; major adverse cardiovascular even
Keywords: bias; comparison of methods; observational studies; regression; BMI; body mass index; HPR; high platelet reactivity; IPW; inverse probability weighting; MACE; major adverse cardiovascular event(s); PS; propensity score(s); RCT; randomized controlled trial
Keywords: Drug-coated balloon; Drug-eluting balloon; In-stent restenosis; Percutaneous coronary intervention; Paclitaxel; Ballon médicamenté; Athérosclérose; Resténose intra-stent; Angioplastie percutanée; Paclitaxel; AMI; acute myocardial infarction; BMS; ba
Keywords: algorithm; diagnostic algorithms; emergency department; high-sensitivity cardiac troponin; rule-in; rule-out; ACS; acute coronary syndrome; ADP; advanced diagnostic pathway; CAD; coronary artery disease; CCTA; coronary computed tomography angiography; cTn
Keywords: AI; annual installed wind capacity; AGC; Automatic Generation Control; ACE; Area Control Error; ACPS1D; Average CPS1 Drop; AC; alternating current; BES; battery energy storage; CI; cumulative installed wind capacity; CDEs; CO2 emissions; CPS; control perf
Keywords: AHA; American heart association; AF; atrial fibrillation; ACS; Acute coronary syndrome; B; Bayesian; CENTRAL; Cochrane Central Register of Controlled Clinical Trials; C; Clopidogrel; CV; Cardiovascular; CrI; Credible Interval; CI; Confidence interval; DAP
Keywords: Aspirin; Clopidogrel; Thienopyridines; Stomach; FFP; fresh frozen plasma; GIB; gastrointestinal bleeding; MACE; major adverse cardiovascular events; OR; odds ratio;
Keywords: Al; aluminium; AP; aniline pentamer; AT; aniline tetramer; AZ91D; Mg-Al-Zn alloy; BaSO4; barium sulfate; BDMS; biodegradable metal-based stent; BDPS; biodegradable polymer-based stent; BDS; biodegradable stent; BECP; biodegradable electrically conduct